Related Experiment Videos
Androgenetic alopecia: pathogenesis and potential for therapy
Justine A Ellis1, Rodney Sinclair, Stephen B Harrap
1Department of Physiology, The University of Melbourne, Victoria 3010, Australia. justine@unimelb.edu.au
Expert Reviews in Molecular Medicine
|October 31, 2003
Summary
Androgenetic alopecia, a common hair loss condition, is driven by genetics and androgens. Identifying contributing genes may lead to more effective treatments for this distressing condition.
Area of Science:
- Dermatology
- Genetics
- Endocrinology
Background:
- Androgenetic alopecia is a prevalent condition causing patterned hair loss in men and women.
- It is characterized by genetic predisposition and androgen influence, leading to follicle miniaturization and altered hair cycles.
- While not a serious health threat, hair loss can cause significant distress.
Purpose of the Study:
- To review the current understanding of androgenetic alopecia pathogenesis.
- To highlight the role of the androgen receptor (AR) gene and the need for identifying other genetic factors.
- To discuss the limitations of current treatments and the potential for future therapeutic developments.
Main Methods:
- Review of existing scientific literature on androgenetic alopecia.
- Analysis of the known genetic and hormonal factors involved in hair follicle cycling and miniaturization.
- Evaluation of the efficacy of current treatment options.
Main Results:
- Androgenetic alopecia involves a transformation of hair follicle growth cycles (anagen/telogen) and progressive miniaturization.
- Androgen action and multiple gene inheritances are crucial for these changes.
- The androgen receptor (AR) gene is the only identified gene to date.
Conclusions:
- Current treatments like finasteride and minoxidil show variable effectiveness.
- Identifying additional genes involved in androgenetic alopecia pathogenesis is essential.
- Future therapies may target the fundamental mechanisms of the condition for improved outcomes.